Records containing: Latent Tuberculosis Infection
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-02-20Evaluation of a Novel Microbiological Diagnostic Test for Latent Mycobacterium Tuberculosis Infection
-
CLINICAL_TRIALS study record update · 2025-10-07Study of The Prevalence of Latent Tuberculosis Infection Among Hemodialysis Patients Using Tuberculin Skin Test at Sohag University Hospital
-
CLINICAL_TRIALS study record update · 2025-07-22Prospective Quality Improvement Project for High-Risk Diabetes Patients
-
CLINICAL_TRIALS study record update · 2025-04-13A Multicenter, Randomized, Double-blind, Controlled Phase Ⅲ Trial of Recombinant Mycobacterium Tuberculosis Fusion Protein (EC) for the Diagnosis of Mycobacterium Tuberculosis Infection in 65-year-olds and Above
-
CLINICAL_TRIALS study record update · 2025-04-01Active Screening of Latent Tuberculosis Infection in School Contacts of Active Tuberculosis Patients
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-03-13Directly Observed Preventive Therapy (DOPT) for Latent Tuberculosis Infection Patients With Poorly Controlled Diabetes Mellitus
-
CLINICAL_TRIALS study record update · 2025-03-13TBTC Study 33. An Evaluation of Adherence to Latent Tuberculosis Infection (LTBI) Treatment With 12 Doses of Once Weekly Rifapentine (RPT) and Isoniazid (INH) Given as Self-administered (SAT) Versus Directly-observed Therapy (DOT): iAdhere.
-
CLINICAL_TRIALS study record update · 2024-09-19To Conduct a Phase IV Clinical Trial of Recombinant Mycobacterium Tuberculosis Fusion Protein in Community Population Aged 6 Months and Above.
-
CLINICAL_TRIALS study record update · 2024-06-25Phase IV Clinical Trial of the Safety, Efficacy, and Immunogenicity of Mycobacterium Vaccae for Injection (Mica) in People Over 15 Years of Age With Latent Mycobacterium Tuberculosis Infection
-
CLINICAL_TRIALS study record update · 2024-04-18Nurse-Led Community Health Worker Adherence Model in 3HP Delivery Among Homeless Adults at Risk for TB Infection and HIV
-
CLINICAL_TRIALS study record update · 2023-12-26Comparing Incidence Rate of Systemic Drug Reactions Under 3HP and 1HP Regimen for Latent Tuberculosis Infection Treatment: a Pragmatic Multicenter Randomized Control Trial
-
CLINICAL_TRIALS study record update · 2022-01-18Diagnosis of Tuberculosis Infection in HIV Co-infected Children
-
CLINICAL_TRIALS study record update · 2021-07-16Performance Evaluation of the VIDAS TB-IGRA Assay.
-
CLINICAL_TRIALS study record update · 2021-02-05Video Directly Observed Therapy (VDOT) to Monitor Short-Course LTBI Treatment
-
CLINICAL_TRIALS study record update · 2021-01-28Prospective Comparison of the Tuberculin Skin Test and Interferon-Gamma Release Assays in Diagnosing Infection With Mycobacterium Tuberculosis and in Predicting Progression to Tuberculosis
-
CLINICAL_TRIALS study record update · 2020-02-21Enhancing the Public Health Impact of Latent Tuberculosis (TB) Infection Diagnosis and Treatment: A Pragmatic Cluster Randomized Trial
-
CLINICAL_TRIALS study record update · 2017-12-19A Randomized Clinical Trial of 4 Months of Rifampin vs. 9 Months of Isoniazid for Latent Tuberculosis Infection. Part 3 - Effectiveness
-
CLINICAL_TRIALS study record update · 2017-12-19A Randomized Trial to Compare Effectiveness of 4 Months Rifampin (4 RIF) With 9 Months Isoniazid (9 INH) in the Prevention of Active TB in Children: The P4v9 Trial
-
CLINICAL_TRIALS study record update · 2017-10-18Adverse Drug Reactions to Antituberculosis Drugs in the Treatment of Latent Tuberculosis Infection in Korean Health Care Workers
-
CLINICAL_TRIALS study record update · 2017-07-02Longitudinal Study of Immune Responses to Mycobacterium Tuberculosis (Mtb) in Subjects With Latent Tuberculosis (TB) Infection(LTBI) With or Without Concomitant Helminth Infection
-
CLINICAL_TRIALS study record update · 2016-12-15Toward a Safe and Reachable Preventive Therapy for LTBI: a Multicenter Randomized Controlled Study in Taiwan
-
CLINICAL_TRIALS study record update · 2016-05-27Comparison of Two Strategies for Therapeutic Decision-making in Tuberculosis Contact Tracing: a Standard Strategy Based on Tuberculin Skin Test (TST) Alone vs TST Combined With QuantiFERON®-TB Gold In-Tube (QFT-IT)
-
CLINICAL_TRIALS study record update · 2015-10-12The Effect of Weekly Text-message Communication on Treatment Completion Among Patients With Latent Tuberculosis Infection: a Randomised Controlled Trial (WelTel LTBI)
-
CLINICAL_TRIALS study record update · 2015-04-09A Double Blind, Placebo Controlled Randomized Trial of Vitamin A Supplementation for Modulation of Mycobacterium Tuberculosis Immune Responses in Children Aged 5-14 Years With Latent Tuberculosis.
-
CLINICAL_TRIALS study record update · 2014-10-15Screening for Latent Tuberculosis Infection (LTBI) in US Army Recruits